Discontinued — last reported Q4 '25
Short-Term Investments
Regeneron Pharmaceuticals Short-Term Investments increased by 5.5% to $5.79B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 10.1%, from $5.26B to $5.79B. Over 5 years (FY 2020 to FY 2025), Short-Term Investments shows an upward trend with a 31.5% CAGR. This is a positive signal — higher values indicate stronger performance for this metric.
Analysis
How to read this metric
Higher levels indicate strong liquidity and significant 'dry powder' for acquisitions or R&D, while lower levels might suggest cash is being deployed into long-term projects or shareholder returns.
Detailed definition
Highly liquid assets and marketable securities that are expected to be converted into cash within one year. For technolo...
Peer comparison
Commonly compared against other cash-rich technology peers to assess capital preservation strategies and short-term solvency.
short_term_investmentsHistorical Data
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $1.84B | $2.36B | $2.81B | $3.70B | $4.17B | $3.53B | $4.64B | $5.04B | $6.99B | $7.76B | $8.11B | $7.92B | $7.89B | $7.78B | $6.52B | $5.26B | $5.47B | $5.94B | $5.49B | $5.79B |
| QoQ Change | — | +28.1% | +19.3% | +31.9% | +12.6% | -15.4% | +31.3% | +8.8% | +38.6% | +11.0% | +4.6% | -2.4% | -0.4% | -1.3% | -16.2% | -19.4% | +4.1% | +8.5% | -7.6% | +5.5% |
| YoY Change | — | — | — | — | +126.9% | +49.9% | +65.0% | +36.1% | +67.6% | +119.8% | +75.0% | +57.0% | +12.8% | +0.3% | -19.6% | -33.6% | -30.6% | -23.7% | -15.9% | +10.1% |
Short-Term Investments at Other Companies
Frequently Asked Questions
- What is Regeneron Pharmaceuticals's short-term investments?
- Regeneron Pharmaceuticals (REGN) reported short-term investments of $5.79B in Q1 2026.
- How has Regeneron Pharmaceuticals's short-term investments changed year-over-year?
- Regeneron Pharmaceuticals's short-term investments increased by 10.1% year-over-year, from $5.26B to $5.79B.
- What is the long-term trend for Regeneron Pharmaceuticals's short-term investments?
- Over 5 years (2020 to 2025), Regeneron Pharmaceuticals's short-term investments has grown at a 31.5% compound annual growth rate (CAGR), from $1.39B to $5.49B.
- What does short-term investments mean?
- Investments like stocks or bonds that the company plans to sell or cash out within the next twelve months.